Antimicrobial Susceptibility Testing Market |Growth| Size | Forecast Year, 2019-2025
Meticulous Research® – leading global market
research company published a research report titled “Antimicrobial
Susceptibility Testing Market by Method (Disk Diffusion, Dilution), Product
(Testing Disks, MIC Strips, Automated Systems), Application (Clinical
Diagnosis, Drug Discovery), End-User (Hospitals, Labs, Pharma Biotech) -
Global Forecast to 2025”.
![]() |
| Antimicrobial Susceptibility Testing Market By Meticulous Research® |
According to this latest publication from Meticulous Research®, the global antimicrobial susceptibility testing market is expected to grow at a CAGR of around 5.6% between 2019-2025 to reach to $3.95 billion by 2025. The high growth of antimicrobial susceptibility testing market is mainly attributed to the rising global incidences of infectious diseases increased funding and government initiatives, and growing need to address concerns of multidrug resistance. The untapped market potential across emerging economies in APAC and Latin America regions offer significant growth opportunities for the players operating in this market. However, stringent government regulations with unfavorable reimbursement is a key factor expected to hinder the adoption of antimicrobial susceptibility testing products over the coming years.
Key Market Segments to Watch
The global antimicrobial susceptibility testing market study
presents historical market data in terms of values (2017 and 2018), estimated
current data (2019), and forecasts for 2025 - by Product (Manual Antimicrobial
Susceptibility Testing, Automated Laboratory Instruments, Consumable& Reagents),
by Method (Disk Diffusion, Automated AST, Dilution), by Application (Clinical
Diagnosis, Drug Discovery, Epidemiology), End User (Diagnostic Laboratories,
Hospitals, Pharma Biotech Industry). The study also evaluates the industry
competitors and analyzes the market at the regional and country levels.
On the basis of product, the manual susceptibility testing
products segment accounted for the largest share of this market in 2018. Manual
testing products are low cost and are easy to use. Thus, these products have
high adoption across clinical labs and hospitals, which has led to a high market
share for this segment. The growth in this market is driven by the increasing
prevalence of infectious diseases which is driving the demand for
susceptibility testing across clinical labs and hospitals.
On the basis of application, the clinical diagnostics segment
accounted for the largest share of this market in 2018, owing to the factors
such as growing awareness about the use of antimicrobial susceptibility testing
methods for diagnostic applications, the rising burden of antimicrobial
resistance, and positive government intervention regarding early disease
screening.
This research report analyzes major geographies and provides
comprehensive analysis for North America (U.S., Canada), Europe (Germany,
France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China,
India and RoAPAC), Latin America, and Middle East & Africa. North America
commanded the largest share of the global antimicrobial susceptibility testing the market in 2018, followed by Europe and the Asia Pacific regions. Easy accessibility
of diagnostic services, high adoption of technologically advanced
susceptibility testing methods, and growing focus on addressing the issues of
antimicrobial resistance has led to a greater share of North America in the
global antimicrobial susceptibility testing market. However, the Asia Pacific the region is expected to grow at the highest CAGR during the forecast period due
to the rising prevalence of the infectious disease, increasing public health
awareness, and increasing consumption of antibiotics which leads to resistance
development among the population.
The key players operating in the global
antimicrobial susceptibility testing market is Thermo Fisher Scientific Inc.
(U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux
S.A. (France), Becton, Dickinson, and Company (U.S.), Danaher Corporation
(U.S.), HiMedia Laboratories (India), MERLIN Diagnostika GmbH (Germany),
Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative
Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China).
Key Topics Covered in This Report:
1.
Introduction
2.
Research Methodology
3. Executive Summary
4. Market Share Analysis
5. Market Insights
6.
Global Antimicrobial Susceptibility
Testing Market, by Product
7.
Global Antimicrobial Susceptibility
Testing Market, by Application
8. Global Antimicrobial Susceptibility Testing Market, by End User
9. Global Antimicrobial Susceptibility Testing Market, by Geography
10. Competitive Landscape
11. Company Profiles
12. Appendix
Browse the in-depth Report at:
Key Questions Answered in The Report
- Which are the high growth market segments in
terms of product, method, application, end-users, and region/countries?
- What was the historical market for
antimicrobial susceptibility testing across the globe?
- What are the market forecasts and estimates
for the period 2019-2025?
- What are the major drivers, restraints,
opportunities, and challenges in the global antimicrobial susceptibility
testing market?
- Who are the major players in the antimicrobial
susceptibility testing market?
- How is the competitive landscape and who are
the market leaders in the global antimicrobial susceptibility testing
market?
- What are the recent developments in the global
antimicrobial susceptibility testing market?
- What are the different strategies adopted by
the major players in the global antimicrobial susceptibility testing
market?
- What are the geographical trends and high
growth regions/ countries?
Contact
Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Website: https://www.meticulousresearch.com/
Connect with us | LinkedIn | Twitter |
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Website: https://www.meticulousresearch.com/
Connect with us | LinkedIn | Twitter |



Comments
Post a Comment